NEW YORK (GenomeWeb) – A busy year in the genomic research tools and molecular diagnostic industries was marked by some significant acquisitions, lawsuits, and uncertainty over regulations and reimbursement for clinical products.
Among the most-read articles on the GenomeWeb site for the year were those tracking patent litigation in the sequencing space, updates on the FDA's plans for lab-developed tests and companion diagnostics, and the acquisition of a pioneer in the microarray space. Below is a list of the 10 articles that gained the most interest among our readers in 2016.
1) Mother's Negligence Suit Against Quest's Athena Could Broadly Impact Genetic Testing Labs
2) Illumina Sues Qiagen for Patent Infringement
3) Illumina Unveils Mini Targeted Sequencer, Semiconductor Sequencing Project at JP Morgan Conference
4) Roche Terminates Dx Technology Development Agreement With Pacific Biosciences
5) FDA Holding Off on Finalizing Regulatory Guidance for Lab-Developed Tests
6) Class Action Lawsuit Against Illumina Alleges Firm and Two Officials Misled Investors
7) Former Affymetrix Execs Offer to Buy Company in Alternative to Thermo Fisher Deal
8) FDA Releases Draft Guidance Outlining Principles of Drug/Diagnostic Codevelopment
9) Illumina and Oxford Nanopore Settle Patent Infringement Lawsuit